ArticleKidney international reports2026

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy.

Matias Trillini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.